Rating Agencies
Share recommendations
Made with ❤ von BGFL
#BGFLapp * beta
Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.
11.04.2024 09:31AM
Study issued by GBC AG
Cenit AG (von GBC AG): BUY
BUY
Sales and earnings in line with expectations; “CENIT 2025” confirmed and
further growth expected for 2024; Acquisitions to take place shortly
With total annual sales of € 184.72 million (previous year: € 162.15
million), CENIT AG slightly exceeded both its own guidance (approx. € 180
million) and our previous est [ … ]
10.04.2024 09:07AM
Study issued by NuWays AG
Rubean AG (von NuWays AG): Kaufen
Kaufen
Topic: Last week, Rubean announced to have quintuples its turnover in Q1´24
against Q1´23. Further,
Rubean signed a contract with SEUR and reduced its cost base by 10% yoy. In
detail:
Turnover increased by 500% yoy to € 493k in Q1, partially due to roll-out
of Rubean´s software to new, large customers, acquired already la [ … ]
10.04.2024 09:01AM
Study issued by NuWays AG
ZEAL Network SE (von NuWays AG): Kaufen
Kaufen
Games business – a second EBITDA accelerator?
Following recent additions to the Games portfolio, we take this opportunity
for another deep dive into the new Games business, highlighting the
favourable business metrics and showing its enormous potential for ZEAL,
once scaled. Here’s our take:
User metrics exceed those of lottery by [ … ]
09.04.2024 09:06AM
Study issued by NuWays AG
Singulus Technologies AG (von NuWays AG): Halten
Halten
Uninspiring FY23 results, positive outlook for FY24e; chg. est.
Topic: Singulus reported uninspiring FY23 figures with top- and bottom-line
below the company’s guidance and our estimates. More importantly, FY24
could feature significant sales and EBIT growth.
FY23 sales decreased 17% yoy to € 73m (eNuW: € 77m), missing the in [ … ]
08.04.2024 09:01AM
Study issued by NuWays AG
CR Energy AG (von NuWays AG): Kaufen
Kaufen
FY ’23 displays strong cash generation and KPIs; chg.
CR Energy released preliminary FY figures, which came in below our
estimates but displayed an improved operating strength of the holding
companies.
FY EBIT came in at € 65m (eNuW: € 80m; eCons: € 73m), which compares to €
75m in FY ’22. The yoy decline can b [ … ]
02.04.2024 09:02AM
Study issued by NuWays AG
ZEAL Network (von NuWays AG): Kaufen
Kaufen
New chapter of growth; added to NuWays AlphaList
ZEAL has openend a new chapter of growth stemming from rising monetization
in the Lottery business and also the Games business from FY'24e onwards. In
sum, we expect sales growth of 25% for this year and a sales CAGR 23-26e of
17%, here's why:
Elevated lottery sales growth: ZEAL has relied on a [ … ]
02.04.2024 09:01AM
Study issued by NuWays AG
Westwing Group (von NuWays AG): Kaufen
Kaufen
Solid FY figures but muted 2024 outlook; est. & PT chg.
Westwing released solid final Q4 results in line with prelims but issued a
mixed FY24e outlook. Sales are expected to develop within a range of -3% to
+4% yoy in FY 24e, implying a 0.5% yoy sales increase at mid-point to €
415-445m (eNuW old: € 460m, eNuW new: € 442m). T [ … ]
28.03.2024 09:02AM
Study issued by NuWays AG
DEMIRE (von NuWays AG): Halten
Halten
Mgmt confirms negotiations regarding bond restructuring
Topic: DEMIRE released an ad-hoc, stating that the company has entered
negotiations with a group of bondholders (Ad hoc Group), which is said to
hold “well over 50%' of the outstanding nominal amount, regarding the
restructuring of its unsecured corporate bond. Mind you, the corporat [ … ]
26.03.2024 02:31PM
Study issued by GBC AG
UmweltBank AG (von GBC AG): BUY
BUY
Transformation year 2023 in line with expectations; further investments in
digitalisation and customer growth expected; return to profitability after
another transformation year 2024; price target: € 9.60; rating: BUY
UmweltBank AG published its preliminary figures for the past financial year
2023 on 18 March 2024. As expected, the pa [ … ]
26.03.2024 12:36PM
Study issued by First Berlin Equity Research GmbH
M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG
(ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 13,20 auf EUR 18,00.
Zusammenfassung:
Wir bekräftigen unsere Kaufempfehlung für die M1 Kliniken AG (M1) und
erhöhen unser Ku [ … ]
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
boersengefluester.de · #BGFL
· © 2025
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies 
boersengefluester.de GmbH
Copyright © 2025
by Gereon Kruse
#BGFL